These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34216102)

  • 1. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
    Tong ZWM; Grant E; Gras S; Wu M; Smith C; Barrett HL; Gallo LA; Short KR
    FEBS J; 2021 Sep; 288(17):5042-5054. PubMed ID: 34216102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
    Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
    J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients.
    Zhao Y; Liu Y; Yi F; Zhang J; Xu Z; Liu Y; Tao Y
    Int Immunopharmacol; 2021 Apr; 93():107406. PubMed ID: 33601246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
    Daryabor G; Atashzar MR; Kabelitz D; Meri S; Kalantar K
    Front Immunol; 2020; 11():1582. PubMed ID: 32793223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Diabetes in Patients Diagnosed With COVID-19.
    Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
    Front Immunol; 2020; 11():576818. PubMed ID: 33335527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.
    Zhou W; Ye S; Wang W; Li S; Hu Q
    J Diabetes Res; 2020; 2020():3918723. PubMed ID: 33062712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report.
    Pal R; Sachdeva N; Mukherjee S; Suri V; Zohmangaihi D; Ram S; Puri GD; Bhalla A; Soni SL; Pandey N; Bhansali A; Bhadada SK
    Diabetes Metab Syndr; 2021; 15(1):193-196. PubMed ID: 33385765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.
    Ali H; Alterki A; Sindhu S; Alahmad B; Hammad M; Al-Sabah S; Alghounaim M; Jamal MH; Aldei A; Mairza MJ; Husain M; Deverajan S; Ahmad R; Cherian P; Alkhairi I; Alkandari A; Abubaker J; Abu-Farha M; Al-Mulla F
    Front Immunol; 2021; 12():752233. PubMed ID: 34899701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19.
    Wang X; Liu Z; Li J; Zhang J; Tian S; Lu S; Qi M; Ma J; Qiu B; Dong W; Xu Y
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32979271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T cell immune response against SARS-CoV-2.
    Moss P
    Nat Immunol; 2022 Feb; 23(2):186-193. PubMed ID: 35105982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-independent benefits of safe sunlight exposure.
    Erem AS; Razzaque MS
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105957. PubMed ID: 34329737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality.
    He Q; Zhao MM; Li MJ; Li XY; Jin JM; Feng YM; Zhang L; Huang WJ; Yang F; Yang JK
    Elife; 2024 Aug; 13():. PubMed ID: 39150053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
    Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
    Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.